| Titolo |
Pubblicato in |
Anno |
| Incorporating immune checkpoint inhibitors in epithelial ovarian cancer |
GYNECOLOGIC ONCOLOGY |
2025 |
| Rechallenge with platinum-based chemotherapy in patients with platinum-resistant ovarian carcinoma: A cohort study |
GYNECOLOGIC ONCOLOGY |
2025 |
| The prognostic impact of molecular classification in endometrial cancer that undergoes fertility-sparing treatment |
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
2025 |
| Racial/ethnic, socioeconomic, and healthcare access disparities in achieving textbook oncologic outcome in advanced ovarian cancer |
GYNECOLOGIC ONCOLOGY |
2025 |
| Primary versus interval cytoreductive surgery in patients with rare epithelial or non-epithelial ovarian cancer |
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
2025 |
| External validation of the annual recurrence risk model for tailored surveillance strategy in patients with cervical cancer |
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
2025 |
| Hormone replacement therapy in gynecological cancer survivors and BRCA mutation carriers: a MITO group survey |
JOURNAL OF GYNECOLOGIC ONCOLOGY |
2024 |
| Stereotactic radiotherapy for managing ovarian cancer oligoprogression under poly (ADP-ribose) polymerase inhibitors (PARPi) |
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
2024 |
| Low-Volume Metastases in Apparent Early-Stage Endometrial Cancer: Prevalence, Clinical Significance, and Future Perspectives |
CANCERS |
2024 |
| Cervical cancer: a new era |
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
2024 |
| Immune Checkpoint Inhibitors in Endometrial Cancer: A Cinderella Story |
ANNALS OF ONCOLOGY |
2024 |
| Impact of molecular classification on recurrence risk in endometrial cancer patients with lymph node metastasis: multicenter retrospective study |
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
2024 |
| Prognostic impact of microscopic residual disease after neoadjuvant chemotherapy in patients undergoing interval debulking surgery for advanced ovarian cancer |
ARCHIVES OF GYNECOLOGY AND OBSTETRICS |
2024 |
| Textbook oncologic outcome is an easy-to-use composite quality measure that is strongly associated with survival in advanced-stage ovarian cancer |
GYNECOLOGIC ONCOLOGY |
2024 |
| Para-aortic lymph node recurrence in surgically treated early-stage cervical cancer without para-aortic lymph node surgical staging |
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
2024 |
| Myeloid neoplasms post PARP inhibitors for ovarian cancer |
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
2023 |
| Poly (ADP-ribose) polymerase inhibitors (PARPi) in ovarian cancer: lessons learned and future directions |
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
2023 |
| Vulvar Paget’s Disease: A Systematic Review of the MITO Rare Cancer Group |
CANCERS |
2023 |
| The efficacy of preoperative low-residue diet on postoperative ileus following cesarean section |
THE JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE |
2023 |
| Systemic therapy de-escalation in advanced ovarian cancer: a new era on the horizon? |
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
2023 |
